Background. Adults with end-stage renal disease are at increased risk of foot ulceration and lower extremity amputation. However, the central determinants of lower limb injury and loss are incompletely understood. Methods. We conducted a systematic review of nonrandomized studies that quantified the major risk factors for foot ulceration and amputation in adults treated with dialysis and analysed patient populations in which risks were greatest. Random-effects meta-analysis was used to generate summary estimates. Results. Thirty studies (48 566 participants) were identified.
A B S T R AC T
Background. Adults with end-stage renal disease are at increased risk of foot ulceration and lower extremity amputation. However, the central determinants of lower limb injury and loss are incompletely understood. Methods. We conducted a systematic review of nonrandomized studies that quantified the major risk factors for foot ulceration and amputation in adults treated with dialysis and analysed patient populations in which risks were greatest. Random-effects meta-analysis was used to generate summary estimates.
Results. Thirty studies (48 566 participants) were identified. Risk factors for foot ulceration and amputation included previous foot ulceration (odds ratios, OR, 17.56 and 70.13), peripheral arterial disease (OR, 7.52 and 9.12), diabetes (OR, 3.76 and 7.48), peripheral neuropathy (OR, 3.24 and 3.36) and coronary artery disease (OR, 3.92 and 2.49). Participants with foot ulceration or amputation had experienced a longer duration of diabetes (mean difference, MD, 4.04 and 6.07 years) and had lower serum albumin levels (MD, −0.23 and −0.13 g/dL). Risk factors for foot ulceration also included retinopathy (OR, 3.03), previous amputation (OR, 15.50) and higher serum phosphorus levels (MD, 0.40 mg/dL), while risk factors for amputation also included male sex (OR, 1.50), current smoking (OR, 2.26) and higher glycated haemoglobin levels (MD, 0.75%). Conclusions. Dialysis patients who have markedly higher risks of ulceration or amputation include those with previous foot ulceration or amputation, peripheral neuropathy, diabetes or macrovascular disease. The temporal relationship between these risk factors and the development of foot ulceration and/ or limb loss is uncertain and requires further study. Stable estimates of the key risk factors for ulceration and amputation can inform the design of future trials investigating clinical interventions to reduce the burden of lower limb disease in the dialysis population.
Keywords: amputation, dialysis, foot ulcer, risk factors, systematic review
I N T R O D U C T I O N
Adults with end-stage renal disease (ESRD) treated with dialysis are at high risk for serious foot complications, including foot ulceration and lower extremity amputation [1] [2] [3] [4] [5] [6] [7] [8] [9] . Risks of limb loss and injury are comparable to those with diabetes [1, 2, 10] . Individuals who are both diabetic and dialysis dependent have even higher rates of foot ulceration and amputation, with estimated cumulative incidence rates of 210 and 58 per 1000 person-years, respectively [11] . Foot ulceration and amputation are major health concerns worldwide and are associated with significant morbidity and mortality [12] . They diminish health-related quality of life and cause considerable financial burden [13, 14] . A recent study [11] found that foot-related hospital admissions were disproportionately higher in dialysis patients (compared with those with a history of foot ulceration), affecting nearly one-third (32.9%) of 150 participants.
There are a limited number of cohort studies in the literature exploring risk factors for the development of lower extremity complications. Most studies comprise small sample sizes and are not comprehensive (i.e. studies do not encompass a full range of risk factors). A systematic synthesis of existing literature is therefore required to quantify the major risk factors for foot ulceration and amputation in adults with ESRD treated with dialysis.
M AT E R I A L S A N D M E T H O D S
This study was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [15] . Two independent reviewers performed the study selection (M.R.K. and K.B.L.), data extraction (M.R.K. and S.D.) and risk of bias assessment (M.R.K. and A.R.). Disagreements between the investigators during the title and abstract review, full-text review, citation tracking/reference scanning and risk of bias assessment were resolved by discussion and consensus.
Search strategy and study selection
We conducted a systematic literature search in MEDLINE, EMBASE, CINAHL, AMED and SPORTDiscus from inception to 9 September 2014 without language restriction. Search strategies are available in Supplementary data, File S1. Articles meeting the inclusion criteria were selected without language restriction. Reference lists of selected articles were also screened for additional eligible studies, and citation tracking via Google Scholar for included articles was also used.
Inclusion and exclusion criteria
Studies were eligible if they reported risk factors for foot ulceration and/or lower extremity amputation in adults with ESRD treated with dialysis (i.e. haemodialysis or peritoneal dialysis). To be included, studies had to be prospective cohort, retrospective cohort or cross-sectional in design. Intervention studies, studies not published in full-text and/or studies not published in peer-reviewed journals were excluded.
Data extraction
Relevant data were extracted from all studies, including study design, population, country and clinical setting; proportion with diabetes, dialysis type (haemodialysis or peritoneal dialysis), primary study objective(s), comparison group (if applicable), methods for risk factor ascertainment, primary study outcome(s), statistical analysis, risk factor estimate, variables adjusted for in analysis and duration of follow-up. Means, standard deviations (SD), sample sizes, odds ratios (ORs), risk ratios, hazard ratios and confidence intervals (CIs) were recorded. Where possible, frequency data were also extracted to calculate OR. Table 1 provides a summary of the characteristics of included studies. The data extraction form for this review is available in Supplementary data, File S2. Eleven requests were made by the authors of this review for additional raw data to complete meta-analyses. Of these requests, additional data were supplied by Ndip et al. [6] , Jones et al. [1] and Pliakogiannis et al. [31] .
Risk of bias assessment Risk of bias in included studies was evaluated according to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) criteria [36] . The domains considered included selection and characteristics of study participants, participation rate, clear description of risk factors and outcome(s), statistical methods and adjustment for potential confounding factors. Reviewers were blinded to the title, author and journal details.
Data analysis
For continuous data, mean differences (MD) and 95% CIs were calculated for individual studies. Dichotomous data were analysed by calculating ORs and 95% CIs from frequency tables of individual studies, where possible. All data were summarized by meta-analysis with the inverse variance method. Prespecified subgroup analyses were performed for the risk factors for foot ulceration and lower extremity amputation in participants with and without diabetes for the following variables: male sex, current smoking, previous foot ulceration, peripheral neuropathy, peripheral arterial disease, foot deformity, skin/ nail pathology and inappropriate footwear. Previous amputation was also investigated as a risk factor for foot ulceration in a subgroup analysis of participants with and without diabetes. Where individual studies comprised subgroups of patients not treated with dialysis, these data were not included in the analysis (i.e. only data from participants on dialysis were included). Statistical heterogeneity between the studies was evaluated by the Cochran's χ 2 (Q-test) and the I 2 statistic [37] [38] [39] . For the Q-test, a P-value of <0.10 was considered statistically significant. A higher P-value was chosen due to the Q-test's low power to detect heterogeneity between studies [38, 39] . The values for the I 2 statistic range from 0 to 100%, with larger values indicating increasing heterogeneity. A random-effects model was used in the meta-analyses, to account for statistical heterogeneity between studies, which also results in a broader CI and a more conservative statement of precision [40] .
We conducted meta-analyses of potential risk factors for foot ulceration and amputation in RevMan (Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). We used the standard continuity correction of 0.5 when estimating summary risks for studies in which no events were reported in one group.
R E S U LT S
Electronic searching retrieved 1733 unique citations of which 1708 were excluded on title and abstract or full-text review analysis ( Figure 1 ). Six additional studies were identified through citation tracking and reference lists, of which five were included. Thirty studies (48 566 participants; 47 639 on haemodialysis; 927 on peritoneal dialysis) were finally included, and their characteristics are presented in Table 1 . The median study size was 176 (range, 31-29 838) participants. The mean age was 63.0 years (95% CI, 62.8 to 63.1) in 16 studies (32 940 participants) 
Garciá Viejo [19] c Haemodialysis N = 51, 100%
69.4 ± 11.6 54.9%
Hatakeyama et al. [20] 
Risk of bias
Risk of bias in the included studies is summarized in Appendix 1. Risk of bias in individual studies is presented in Supplementary data, File S5. Of the 30 included studies, only 7 (23%) comprising 9951 participants were considered low risk on all 'risk of bias' categories. In 23 studies (77%), assessed risk factors were clearly described. Similarly, 22 studies (73%) adequately described their main study outcome(s). The majority of studies sufficiently described the source and sampling frame (80%), participant eligibility criteria (77%), participation rate (90%), characteristics of study participants (93%) and those lost to follow-up (93%). Only 18 studies (60%) clearly described the statistical methods used and less than half of the studies (43%) provided adequate adjustment for potential confounding factors in their analyses.
Risk factors for foot ulceration and amputation
Due to the extensive results generated by this review (i.e. multiple risk factors for foot ulceration and/or amputation presented in the literature), we have only reported 'significant' risk factors identified in the meta-analyses. 'Non-significant' risk factors and related individual study results are discussed in detail in Supplementary data, File S6. Forest plots of all risk factors are presented in Figures 2 and 3 .
Foot ulceration
Ten studies [1-3, 6, 16, 19, 23, 26, 31, 35] provided extractable data for meta-analyses. The overall risk factors for foot ulceration are shown in Figure 2 . Non-significant risk factors for foot ulceration included increasing age, male sex, increasing body mass index, current smoking, longer dialysis duration, peripheral arterial disease symptoms, peripheral neuropathy symptoms, elevated glycated haemoglobin or serum calcium levels, lower haemoglobin levels, foot deformity, skin/nail pathology, inappropriate footwear and podiatry attendance.
Comorbidities. Diabetes mellitus increased the odds of foot ulceration by nearly 4-fold (Figure 2) . The mean duration of diabetes in those with foot ulceration was 4 years longer than those without ulceration, while the presence of retinopathy more than tripled the odds of having a foot ulcer (Figure 2 ). In addition, comorbid coronary artery disease increased the odds of having a foot ulcer by nearly 4-fold (Figure 2) .
Laboratory values. The mean serum albumin levels in those with a foot ulcer were 0.23 g/dL lower than those without (Figure 2) . The mean serum phosphorus levels were 0.40 mg/dL higher in those with foot ulceration (Figure 2 ).
Lower extremity complications. A past history of foot ulceration increased the odds of current foot ulceration >17-fold ( Figure 2 ). Likewise, a past history of amputation increased the odds of having a current (contralateral) foot ulcer by >15-fold (Figure 2 ). In addition, coexisting peripheral neuropathy and peripheral arterial disease increased the odds of foot ulceration by >3-fold and 7-fold, respectively (Figure 2) .
There was no significant statistical heterogeneity found in the meta-analyses for risk factors including: diabetes, diabetes duration, retinopathy, coronary artery disease, serum albumin, serum phosphorus, previous foot ulceration, previous amputation, peripheral neuropathy and peripheral arterial disease (I² = 22, 0, 41, 0, 0, 17, 55, 41, 48 and 23%, respectively).
Lower extremity amputation
Ten studies [1-3, 6, 8-9, 23, 25, 27, 31] provided extractable data for meta-analyses. The overall results for risk factors of lower extremity amputation are shown in Figure 3 . Nonsignificant risk factors for amputation included increasing age, increasing body mass index, longer dialysis duration, insulin treatment, retinopathy, cerebrovascular disease, hypertension, hyperlipidaemia, reduced dialysis treatment adequacy (i.e. Kt/V) or creatinine clearance, elevated phosphate levels, foot deformity, skin/nail pathology and podiatry attendance.
Participant characteristics. Men had higher odds of lower extremity amputation than women (one and a half fold), as did current smokers (2-fold) (Figure 3 ).
Comorbidities. Coronary artery disease more than doubled the odds of having had an amputation (Figure 3) . Diabetes mellitus increased the odds of having had an amputation >7-fold ( Figure 3) . The mean duration of diabetes in those who had had an amputation was 6.1 years longer than those without an amputation (Figure 3) .
Laboratory values. The mean serum albumin levels in those who had had an amputation were 0.13 g/dL less than those without (Figure 3 ). The mean glycated haemoglobin level was 0.75% higher in those with history of amputation (Figure 3 ).
Lower extremity complications. A past history of foot ulceration increased the odds of having had an amputation >70-fold ( Figure 3) . Peripheral neuropathy increased the odds of having had an amputation (3-fold), as did peripheral arterial disease (9-fold) ( Figure 3) .
There was no significant statistical heterogeneity found in the meta-analyses for risk factors including: male sex, current smoking, coronary artery disease, diabetes, diabetes duration, serum albumin, glycated haemoglobin, previous foot ulceration, peripheral neuropathy and peripheral arterial disease (I² = 7, 0, 32, 0, 0, 0, 37, 0, 50, and 0%, respectively) .
O R I G I N A L A R T I C L E

Subgroup analyses
The results for the subgroup analyses are shown in Appendices 2 and 3.
Foot ulceration. In adults with diabetes and previous ulceration, the odds of foot ulceration was 39.25 (95% CI, 7.86 to 196.07) while the odds of foot ulceration in those without diabetes and previous ulceration was 3.70 (95% CI, 0.62 to 22.05). Risk of foot ulceration was not strongly modified by the presence of diabetes for the following risk factors: male sex (P = 0.79), current smoking (P = 0.80), previous amputation (P = 0.70), peripheral neuropathy (P = 0.56), peripheral arterial disease (P = 0.25), foot deformity (P = 0.48), skin/nail pathology (P = 0.39) and inappropriate footwear (P = 0.68).
Lower extremity amputation. Risk of lower extremity amputation was not strongly modified by the presence of diabetes for the following risk factors: male sex (P = 0.54), current smoking (P = 0.92), previous foot ulcer (P = 0.86), peripheral neuropathy (P = 0.79), peripheral arterial disease (P = 0.81), foot deformity (P = 0.70), skin/nail pathology (P = 0.54) and inappropriate footwear (P = 0.97).
F I G U R E 2 : Unadjusted summary estimates for factors associated with foot ulceration in adult dialysis patients. Each diamond indicates the point estimate and 95% confidence interval for the specified factor summarized across all studies providing extractable data.
D I S C U S S I O N
We quantified, for the first time, all major risk factors associated with serious lower extremity complications in dialysis patients. The risk of foot ulceration was higher in the case of previous foot ulceration (OR, 17.56), lower extremity amputation (OR, 15.50), peripheral arterial disease (OR, 7.52), coronary artery disease (OR, 3.92), diabetes mellitus (OR, 3.76), peripheral neuropathy (OR, 3.24), retinopathy (OR, 3.03) and higher serum phosphorus levels (MD, 0.40 mg/dL). The risk of lower extremity amputation was higher in the presence of previous foot ulceration (OR, 70.13), peripheral arterial disease (OR, 9.12), diabetes mellitus (OR, 7.48), peripheral neuropathy (OR, 3.36), coronary artery disease (OR, 2.49), current smoking (OR, 2.26), male sex (OR, 1.50) and higher glycated haemoglobin levels (MD, 0.75%). Foot ulceration or amputation was more common in people with longer duration of diabetes (MD, 4.04 and 6.07 years) and lower serum albumin levels (MD, −0.23 and −0.13 g/dL). These data suggest strongly that dialysis patients with previous foot ulceration or limb loss and those with peripheral arterial disease face extremely high risks of disabling complications.
We also established stable comprehensive estimates of risk for foot ulceration and amputation in the dialysis population, which can assist in the identification of dialysis patients at the F I G U R E 3 : Unadjusted summary estimates for factors associated with lower extremity amputation in adult dialysis patients. Each diamond indicates the point estimate and 95% confidence interval for the specified factor summarized across all studies providing extractable data.
O R I G I N A L A R T I C L E
potential to significantly improve health-related quality of life in these individuals. Studies suggest that chiropody ( podiatry), diabetes education or foot care prevention programs can reduce the rate of foot ulcers and amputations in dialysis patients [25, [41] [42] [43] [44] [45] . Accordingly, there is a need for clinical trials that evaluate the effectiveness of these interventions for the prevention or management of foot ulceration and amputation in the dialysis population. Further prospective studies are also needed to elucidate a temporal relationship between these risk factors and the development of foot ulceration.
In our review, dialysis patients with diabetes mellitus were more than three times as likely to have a current foot ulcer and more than seven times as likely to have had an amputation. Other studies have reported similar findings [9, 10, [46] [47] [48] . Importantly, the rate of amputation in patients with ESRD and diabetes is 10 times greater compared with the general diabetes population [46] . Furthermore, we found that the mean duration of diabetes was significantly longer in those with foot ulceration (4 years longer) and in those with a history of amputation (6 years longer), compared with those without these lower extremity complications. These findings indicate that populations with severe kidney disease and diabetes are at particularly high risk for lower limb loss and injury and should be preferentially included in future research.
Interestingly, in our meta-analysis, longer duration of dialysis was not a significant risk factor for foot ulceration or amputation (refer to Figures 2 and 3 ). This is in contrast to previous studies where the opposite was found [7, 18, 25] . It is possible that this finding is due to survival bias; adults with foot disease may experience premature mortality from vascular causes and be more likely to experience a shorter rather than longer time treated with dialysis. Another issue that could affect risk of foot ulceration or amputation is the mode of dialysis; however, we could not analyse this due to the heterogeneity of available data. Although, previous studies suggest that mode of dialysis may increase the risk of lower extremity complications [6, 31] . Further prospective studies are required to answer this question.
We found a significant decrease in mean serum albumin levels between those with and without amputation (0.13 g/dL lower) and between those with and without foot ulceration (0.23 g/dL lower). Hypoalbuminaemia is thought to be caused by a combination of systemic inflammation (reflected by higher C-reactive protein concentrations), malnutrition and reduced synthesis and/or increased degradation of albumin [13] . Our review also identified a significant increase in mean glycated haemoglobin levels (0.75% higher) for those with a history of amputation. Higher glycated haemoglobin and lower serum albumin levels can significantly delay wound healing [13] , which may increase the risk of infection and lead to amputation. These findings suggest potential causal pathways for limb injury in the setting of dialysis that warrant further evaluation.
Our review found that those with peripheral neuropathy were more likely to have both foot ulceration and amputation (3-fold higher). Sensory loss in the feet as a result of uraemic polyneuropathy can give rise to repetitive stress and unnoticed injuries, which can cause neuropathic ulceration [13] . In addition, the motor component of polyneuropathy can lead to muscle atrophy with associated foot deformity, which may increase localized foot pressures and cause subsequent tissue breakdown [13] . Furthermore, the autonomic component of uraemic and/or diabetic polyneuropathy can cause dryness and fissuring of the skin, making it more prone to damage from minor trauma and thus increase the risk of infection [13] . Although foot deformity and skin/nail pathology were not found to be significant risk factors in this review (refer to Figures 2 and 3) , many studies report a high prevalence of these foot problems in their dialysis cohorts (ranging from 15 to 70% and 22 to 85%, respectively).
Given that adequate blood supply is essential for timely and ordered healing, it is not surprising that peripheral arterial disease was found to be significantly associated with foot ulceration (7-fold) and amputation (9-fold). Of note in our review, male sex and current smoking were also found to increase the odds of amputation, which may have been linked to the development of peripheral arterial disease. Individuals on dialysis are predisposed to the development of peripheral arterial disease from accelerated atherosclerotic plaque formation due to traditional risk factors for peripheral arterial disease (e.g. older age, smoking history, male sex, hypertension, diabetes) and risk factors specifically related to renal disease (including malnutrition, chronic inflammation, fluid retention, abnormal mineral metabolism, alterations in the renin-angiotensin system, lipoprotein imbalances, hyperhomocysteinaemia and oxidative stress) [49] . Haemodialysis therapy has also been linked to poor microcirculation and oxygen supply to the skin of the lower extremities, both during and up to 4 hours following dialysis treatment [50] [51] [52] .
Our review also found an increase in mean serum phosphorus levels (0.40 mg/dL higher) in those with foot ulceration. Patients with ESRD have elevated serum phosphorus levels due to diminished renal clearance. Elevated phosphorus is also associated with vascular calcification, which in turn aggravates the development of peripheral arterial disease and therefore may increase the risk of these lower limb complications [13, 53, 54] . This is the first systematic review to present comprehensive, stable estimates of risk for foot ulceration and lower extremity amputation in the dialysis population. The strengths of this systematic review include the rigorous search strategy and the standardized methods conducted by two independent reviewers and the relevance of the findings to clinical practice and research prioritization. In addition, the summary estimates had little or no evidence of heterogeneity.
This review has limitations that need to be considered when interpreting the results. The available data are largely derived from retrospective and cross-sectional studies and therefore have limited ability to determine temporal association between risk factors and foot disease. The review was also limited by data that were not presented in the sourced article of some included studies. Although all primary authors were contacted in cases like this, not all authors supplied raw data when requested. Imprecise results for some risk factors may have been due to small sample sizes and unexplained between-study heterogeneity.
In addition, we sourced unadjusted risk data from nonrandomized studies that are at greater risk of confounding from measured and unmeasured factors. However, we made every attempt to address heterogeneity by standard measures (e.g. visual inspection and taking into account the I 2 statistic) and by conducting subgroup analyses.
In summary, our systematic review found that dialysis patients most at risk for foot ulceration were those with previous foot ulceration or lower extremity amputation, peripheral arterial disease, coronary artery disease and diabetes mellitus (increasing with longer duration of disease). For amputation, dialysis patients most at risk were those with previous foot ulceration, peripheral arterial disease, diabetes mellitus (increasing with longer duration of disease) and peripheral neuropathy. Most of the studies reviewed were retrospective or cross-sectional. There is a clear need for prospective observational and interventional studies to confirm these findings, identify other risk factors and determine effective strategies to reduce the risk of ulceration and/or amputation in the dialysis population. 
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